Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-21 6:26 pm Sale | 2025-01-17 | 13D | Haleon plc HLN | PFIZER INC PFE | 661,709,764 7.300% | -700,000,000 (-51.41%) | Filing History |
| 2025-01-16 4:34 pm Unchanged | 2025-01-14 | 13D | Haleon plc HLN | PFIZER INC PFE | 1,361,709,764 15.000% | 0 (Unchanged) | Filing History |
| 2024-10-03 6:59 pm Sale | 2024-10-03 | 13D | Haleon plc HLN | PFIZER INC PFE | 1,361,709,764 15.000% | -700,526,315 (-33.97%) | Filing History |
| 2024-10-01 7:38 pm Unchanged | 2024-09-30 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | 0 (Unchanged) | Filing History |
| 2024-08-05 6:12 pm Sale | 2024-08-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 0 0.000% | -27,349,211 (Position Closed) | Filing History |
| 2024-07-29 4:33 pm Unchanged | 2024-07-29 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | 0 (Unchanged) | Filing History |
| 2024-03-22 09:05 am Sale | 2024-03-21 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | -892,827,547 (-30.21%) | Filing History |
| 2024-03-19 8:48 pm Unchanged | 2024-03-19 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2024-03-15 07:45 am Unchanged | 2024-01-29 | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 4.960% | 0 (Unchanged) | Filing History |
| 2024-02-14 3:48 pm Purchase | 2023-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR | PFIZER INC PFE | 2,243,850 3.470% | 2,243,850 (New Position) | Filing History |
| 2024-02-14 3:31 pm Purchase | 2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN | PFIZER INC PFE | 389,429 0.950% | 389,429 (New Position) | Filing History |
| 2024-02-14 2:29 pm Purchase | 2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | PFIZER INC PFE | 1,362,499 4.580% | 1,362,499 (New Position) | Filing History |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | Cellectis S.A. CLLS | PFIZER INC PFE | 2,786,924 3.890% | 2,786,924 (New Position) | Filing History |
| 2024-02-14 2:19 pm Unchanged | 2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO | PFIZER INC PFE | 2,525,252 4.530% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | Pfizer Inc. PFE | VANGUARD GROUP INC | 506,479,807 8.970% | 4,843,587 (+0.97%) | Filing History |
| 2024-01-29 5:01 pm Sale | 2024-01-25 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 0 0.000% | -3,978,540 (Position Closed) | Filing History |
| 2024-01-29 1:04 pm Purchase | 2023-12-31 | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 287,875,814 5.100% | 2,932,117 (+1.03%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Pfizer Inc. PFE | BlackRock Inc. BLK | 434,748,255 7.700% | -8,120,506 (-1.83%) | Filing History |
| 2024-01-19 4:20 pm Unchanged | 2024-01-16 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2024-01-10 4:12 pm Unchanged | 2024-01-08 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 11.260% | 0 (Unchanged) | Filing History |